BioScrip, Home Solutions tweak deal
By HME News Staff
Updated Tue September 6, 2016
DENVER - The price tag for BioScrip's acquisition of Home Solutions has dropped from $85 million to $75 million, according to news reports. The cash component of the consideration has been dropped from $80 million to $67.5 million. To speed up the deal, the two companies have also agreed to eliminate the need for stockholder approval; instead, they have agreed to a shareholder meeting following the close of the deal to seek such approval and provide Home Solutions with certain contractual protections in the event such approval is not obtained. BioScrip and Home Solutions now expect to close on the deal in the second week of September. Together, the companies are expected to generate more than $1 billion in revenues.
Comments